BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 22
• 23
• 26
• 27
• 28
• 29
• 30

• Drug Development

  GenSight Biologics Receives Approval To Include Teenage Patients In RESCUE And REVERSE Phase III Trials With GS010 In Leber’s Hereditary Optic Neuropathy

  September 8, 2016

   · 

  4 min read
• Provectus To Present At Rodman & Renshaw’s 18th Annual Global Investment Conference

  September 8, 2016

   · 

  3 min read
• Business

  Arcadia Biosciences Names New Chief Financial Officer

  September 8, 2016

   · 

  3 min read
• Business

  StemGenex Announces Steven A. Brody, M.D., Ph.D. Chief Scientific Officer

  September 8, 2016

   · 

  3 min read
• Valensa International, LLC Announces Immunity-Enhancing Immunum Chewable Tablets

  September 8, 2016

   · 

  3 min read
• Business

  Redx Pharma CFO to Step Down Just as Former AstraZeneca PLC Exec Joins Roster

  September 8, 2016

   · 

  1 min read
• BioMidwest

  Boston Scientific Dumps $25 Million Into Veniti

  September 8, 2016

   · 

  2 min read
• Policy

  Apple Raises Explicit Guidelines for Mobile Medical and Health App Developers

  September 8, 2016

   · 

  1 min read
• Biotech Bay

  Bay Area’s Chrono Scores $47.6 Million for Wearable to Deliver Nicotine Fix Before Smokers Even Wake Up

  September 8, 2016

   · 

  3 min read
• Deals

  Valeant CEO Says He’ll Never Say Never to Selling Core Assets Like Bausch & Lomb

  September 8, 2016

   · 

  1 min read